US2012122242A1PendingUtilityA1

Method for assessing arteriosclerosis and diabetic nephropathy

46
Assignee: HIROWATARI YUJIPriority: Mar 7, 2005Filed: Jan 26, 2012Published: May 17, 2012
Est. expiryMar 7, 2025(expired)· nominal 20-yr term from priority
Inventors:Yuji HirowatariKatsuko HaraHakuo Takahashi
G01N 2800/323G01N 2800/347G01N 33/942G01N 2800/042Y10T436/145555
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for assessing arteriosclerosis comprising measuring the serotonin level in whole blood, serum or platelet-rich plasma and rating the serotonin level on such a scale that the lower it is, the more serious the arteriosclerosis is.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . A method for assessing diabetic nephropathy comprising measuring the serotonin level in platelet-poor plasma and rating the serotonin level on such a scale that the higher it is, the more serious the nephropathy is. 
     
     
         5 . (canceled)

Join the waitlist — get patent alerts

Track US2012122242A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.